Literature DB >> 25488203

Elevated serum thyroid-stimulating hormone is associated with decreased anti-Müllerian hormone in infertile women of reproductive age.

Keiji Kuroda1, Toyoyoshi Uchida, Saki Nagai, Rie Ozaki, Takashi Yamaguchi, Yuichi Sato, Jan J Brosens, Satoru Takeda.   

Abstract

PURPOSE: Thyroid dysfunction and autoimmune thyroiditis are associated with fertility in women of reproductive age. Anti-Müllerian hormone (AMH), a known biomarker of ovarian function, may be affected by impaired thyroid function; however, the relationship between AMH and thyroid hormone has not been elucidated.
METHODS: In this case-control study, to identify the impact of thyroid hormone on ovarian reserve, we recruited 67 consecutive Japanese infertile patients and 27 normal fertile women aged 30-39 years without impact factors on thyroid and ovarian functions between 2012 and 2013. We assessed patient age, BMI and AMH, prolactin, TSH and FT4 levels of all study participations as independent variables. To evaluate the relationship between AMH and thyroid hormone, we matched patients by age and body mass index as confounding factors using 1:1 matching for statistical analysis of healthy fertile women and infertile patients and obtained 23 pairs. Then, independent variables were subjected to multiple regression analysis.
RESULTS: Multiple regression analysis showed that both thyroid-stimulating hormone (TSH) levels and patient age were negatively correlated with AMH levels in infertile patients (patient age and TSH: standardized partial regression coefficient (β), -0.534 and -0.361; p = 0.003 and 0.036, respectively), but not in normal fertile women.
CONCLUSIONS: AMH levels were inversely correlated with TSH levels in infertile women of reproductive age.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25488203      PMCID: PMC4354178          DOI: 10.1007/s10815-014-0397-7

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  25 in total

1.  Serum prolactin and TSH in an in vitro fertilization population: is there a link between fertilization and thyroid function?

Authors:  D W Cramer; P M Sluss; R D Powers; P McShane; E S Ginsburgs; M D Hornstein; A F Vitonis; R L Barbieri
Journal:  J Assist Reprod Genet       Date:  2003-06       Impact factor: 3.412

2.  Correlation of ovarian reserve tests with histologically determined primordial follicle number.

Authors:  Karl R Hansen; George M Hodnett; Nicholas Knowlton; LaTasha B Craig
Journal:  Fertil Steril       Date:  2010-06-01       Impact factor: 7.329

3.  Antimüllerian hormone serum levels: a putative marker for ovarian aging.

Authors:  Annemarie de Vet; Joop S E Laven; Frank H de Jong; Axel P N Themmen; Bart C J M Fauser
Journal:  Fertil Steril       Date:  2002-02       Impact factor: 7.329

Review 4.  Effects of cigarette smoking on reproduction.

Authors:  C Dechanet; T Anahory; J C Mathieu Daude; X Quantin; L Reyftmann; S Hamamah; B Hedon; H Dechaud
Journal:  Hum Reprod Update       Date:  2010-08-04       Impact factor: 15.610

5.  Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis.

Authors:  Michio Kitajima; Sylvie Defrère; Marie-Madeleine Dolmans; Sebastien Colette; Jean Squifflet; Anne Van Langendonckt; Jacques Donnez
Journal:  Fertil Steril       Date:  2011-07-29       Impact factor: 7.329

Review 6.  Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review.

Authors:  Emmy van den Boogaard; Rosa Vissenberg; Jolande A Land; Madelon van Wely; Joris A M van der Post; Mariette Goddijn; Peter H Bisschop
Journal:  Hum Reprod Update       Date:  2011-05-28       Impact factor: 15.610

7.  The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis.

Authors:  Wakana Hirokawa; Akira Iwase; Maki Goto; Sachiko Takikawa; Yoshinari Nagatomo; Tatsuo Nakahara; Bayasula Bayasula; Tomoko Nakamura; Shuichi Manabe; Fumitaka Kikkawa
Journal:  Hum Reprod       Date:  2011-02-02       Impact factor: 6.918

Review 8.  Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta-analysis of RCTs.

Authors:  B Velkeniers; A Van Meerhaeghe; K Poppe; D Unuane; H Tournaye; P Haentjens
Journal:  Hum Reprod Update       Date:  2013-01-17       Impact factor: 15.610

Review 9.  Molecular basis of thyrotropin and thyroid hormone action during implantation and early development.

Authors:  Martina Colicchia; Luisa Campagnolo; Enke Baldini; Salvatore Ulisse; Herbert Valensise; Costanzo Moretti
Journal:  Hum Reprod Update       Date:  2014-06-18       Impact factor: 15.610

10.  Lack of Serum anti-Mullerian hormone responses after recombinant human chorionic gonadotropin stimulation in women with polycystic ovary syndrome.

Authors:  Heidi Cook-Andersen; Sandy S Chuan; Kevin Maas; Marcus A Rosencrantz; H Irene Su; Mark Lawson; Helen D Mason; R Jeffrey Chang
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

View more
  11 in total

1.  Anti-Müllerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer.

Authors:  Massimo Giusti; Miranda Mittica; Paola Comite; Claudia Campana; Stefano Gay; Michele Mussap
Journal:  Endocrine       Date:  2018-01-04       Impact factor: 3.633

2.  Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity.

Authors:  Flavia Magri; Lucia Schena; Valentina Capelli; Margherita Gaiti; Francesca Zerbini; Emanuela Brambilla; Mario Rotondi; Mara De Amici; Arsenio Spinillo; Rossella E Nappi; Luca Chiovato
Journal:  Reprod Biol Endocrinol       Date:  2015-09-21       Impact factor: 5.211

3.  What affects functional ovarian reserve, thyroid function or thyroid autoimmunity?

Authors:  Andrea Weghofer; David H Barad; Sarah Darmon; Vitaly A Kushnir; Norbert Gleicher
Journal:  Reprod Biol Endocrinol       Date:  2016-05-10       Impact factor: 5.211

4.  Overtime trend of thyroid hormones and thyroid autoimmunity and ovarian reserve: a longitudinal population study with a 12-year follow up.

Authors:  Sara Bahri; Fahimeh Ramezani Tehrani; Atieh Amouzgar; Maryam Rahmati; Maryam Tohidi; Maryam Vasheghani; Fereidoun Azizi
Journal:  BMC Endocr Disord       Date:  2019-05-07       Impact factor: 2.763

5.  Cross-sectional and prospective study on anti-Müllerian hormone changes in a cohort of pre-menopausal women with a history of differentiated thyroid cancer.

Authors:  Miranda Mittica; Andrea Dotto; Martina Comina; Marsida Teliti; Eleonora Monti; Massimo Giusti
Journal:  Thyroid Res       Date:  2020-01-10

6.  Correlation Analysis Between Ovarian Reserve and Thyroid Hormone Levels in Infertile Women of Reproductive Age.

Authors:  Jie Wu; Ying-Jie Zhao; Min Wang; Ming-Qiang Tang; Yao-Fang Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-27       Impact factor: 5.555

7.  Evaluation of serum anti-Müllerian hormone levels in women with Hashimoto thyroiditis in the reproductive age

Authors:  İlknur Öztürk Ünsal; Sema Hepşen; Pınar Akhanlı; Murat Çalapkulu; Muhammed Erkam Sencar; Ali Yalçındağ; Erman Çakal
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

8.  Evaluation of ovarian reserve in women with overt or subclinical hypothyroidism.

Authors:  Ferit Kerim Kucukler; Umit Gorkem; Yasin Simsek; Ramazan Kocabas; Serdar Guler
Journal:  Arch Med Sci       Date:  2016-03-23       Impact factor: 3.318

9.  Phenomic Impact of Genetically-Determined Euthyroid Function and Molecular Differences between Thyroid Disorders.

Authors:  Silvia Ravera; Nancy Carrasco; Joel Gelernter; Renato Polimanti
Journal:  J Clin Med       Date:  2018-09-21       Impact factor: 4.241

Review 10.  Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.

Authors:  Loes M E Moolhuijsen; Jenny A Visser
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.